|
LRRC58 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.24469995316434E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28170002073369E-09 |
| Normal-vs-Stage2 |
3.68430000000641E-05 |
| Normal-vs-Stage3 |
2.64199995214653E-09 |
| Normal-vs-Stage4 |
1.34959998732143E-09 |
| Stage1-vs-Stage2 |
3.599000E-01 |
| Stage1-vs-Stage3 |
3.982000E-01 |
| Stage1-vs-Stage4 |
1.908240E-01 |
| Stage2-vs-Stage3 |
1.625750E-01 |
| Stage2-vs-Stage4 |
7.678300E-02 |
| Stage3-vs-Stage4 |
5.296800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.64289981197908E-10 |
| Normal-vs-AfricanAmerican |
2.441800E-03 |
| Normal-vs-Asian |
1.75509999977841E-07 |
| Caucasian-vs-AfricanAmerican |
1.067810E-01 |
| Caucasian-vs-Asian |
6.745200E-01 |
| AfricanAmerican-vs-Asian |
2.531000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.96159999354961E-09 |
| Normal-vs-Female |
6.94699997527692E-09 |
| Male-vs-Female |
3.633000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.012500166515E-10 |
| Normal-vs-Age(41-60Yrs) |
1.71750003108428E-09 |
| Normal-vs-Age(61-80Yrs) |
3.0298999975642E-08 |
| Normal-vs-Age(81-100Yrs) |
4.544900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.503400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.627400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.868200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.312000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.520000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.764600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.239800E-02 |
| Classical-VS-Follicular |
5.430600E-01 |
| Classical-VS-Other |
4.026800E-01 |
| Classical-VS-Normal |
3.14660000277911E-08 |
| Tall-VS-Follicular |
3.490200E-02 |
| Tall-VS-Other |
9.918000E-01 |
| Tall-VS-Normal |
2.504299989603E-09 |
| Follicular-VS-Other |
3.461200E-01 |
| Follicular-VS-Normal |
2.62939999995382E-07 |
| Other-VS-Normal |
3.761800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.58026974523318E-12 |
| Normal-vs-N1 |
3.69509978170868E-10 |
| N0-vs-N1 |
7.748200E-02 |
|
|
